Tennis Elbow Trial
CompletedNot applicableNCT00888225
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Epi-X is a multicentered randomized controlled clinical trial of chronic lateral epicondylitis with parallel group design and two phases. In the first phase physical exercise treatment is given in the intervention group and expectance in the reference group. In phase 2 eccentric exercise versus concentric is tested.
Study details
- Official title
- Chronic Lateral Epicondylitis. A Randomized Controlled Clinical Trial of Two Physical Training Concepts With Special Reference to Etiology and Treatment Effect
- Conditions
- Lateral Epicondylitis
- Interventions
- Procedure: Eccentric exercise
- Procedure: Concentric exercise
- Sponsor
- Uppsala University
- Collaborators
- The Swedish Research Council; Amersham Foundation; Uppsala County Council, Sweden
- Start date
- 2003-10
- Primary completion
- 2008-01
- Sex
- All
- Age range
- from 20 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Sweden
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Verified tennis elbow for more than three months * Age 20-75 years * Informed consent Exclusion Criteria: * Inability to understand or follow instructions * Inability to read or fill in questionnaires * Inability to participate at measurement sessions * Supinator syndrome * Compartment syndrome of anconeus muscle * Rhizopathy of arm * Inflammatory joint or soft tissue disease including fibromyalgia * Previous surgery because of tennis elbow
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00888225